Skip to main content
. 2020 Jul 17:NEJMoa2021436. doi: 10.1056/NEJMoa2021436

Table 2. Primary and Secondary Outcomes.

Outcome Dexamethasone
(N=2104)
Usual Care
(N=4321)
Rate or Risk Ratio
(95% CI)*
no./total no. of patients (%)
Primary outcome
Mortality at 28 days 482/2104 (22.9) 1110/4321 (25.7) 0.83 (0.75–0.93)
Secondary outcomes
Discharged from hospital within 28 days 1413/2104 (67.2) 2745/4321 (63.5) 1.10 (1.03–1.17)
Invasive mechanical ventilation or death 456/1780 (25.6) 994/3638 (27.3) 0.92 (0.84–1.01)
Invasive mechanical ventilation 102/1780 (5.7) 285/3638 (7.8) 0.77 (0.62–0.95)
Death 387/1780 (21.7) 827/3638 (22.7) 0.93 (0.84–1.03)
*

Rate ratios have been adjusted for age with respect to the outcomes of 28-day mortality and hospital discharge. Risk ratios have been adjusted for age with respect to the outcome of receipt of invasive mechanical ventilation or death and its subcomponents.

Excluded from this category are patients who were receiving invasive mechanical ventilation at randomization.